AdaptHealth
AHCO
154 hedge funds and large institutions have $1.52B invested in AdaptHealth in 2022 Q1 according to their latest regulatory filings, with 27 funds opening new positions, 60 increasing their positions, 45 reducing their positions, and 22 closing their positions.
254% more call options, than puts
Call options by funds: $2.75M | Put options by funds: $778K
33% more repeat investments, than reductions
Existing positions increased: 60 | Existing positions reduced: 45
23% more first-time investments, than exits
New positions opened: 27 | Existing positions closed: 22
4.26% more ownership
Funds ownership: 66.69% → 70.95% (+4.3%)
1% more funds holding
Funds holding: 152 → 154 (+2)
29% less capital invested
Capital invested by funds: $2.15B → $1.52B (-$627M)
33% less funds holding in top 10
Funds holding in top 10: 6 → 4 (-2)
Top Buyers
| 1 |
Morgan Stanley
New York
|
+$106M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
+$96.4M |
| 3 |
DM
Deerfield Management
New York
|
+$25.6M |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$13.1M |
| 5 |
Sumitomo Mitsui Trust Group
Minato-Ku, Tokyo,
Japan
|
+$12.2M |
Top Sellers
| 1 |
Viking Global Investors
Stamford,
Connecticut
|
-$96.6M |
| 2 |
Swedbank
Stockholm,
Sweden
|
-$30.3M |
| 3 |
Point72 Asset Management
Stamford,
Connecticut
|
-$25.9M |
| 4 |
ITP
Iron Triangle Partners
Cos Cob,
Connecticut
|
-$17.1M |
| 5 |
SHI
SV Health Investors
Boston,
Massachusetts
|
-$11.7M |
AHCO Hedge Fund Activity: Q1 2022 in Review
154 of the 6,340 institutional investors tracked by Wall St. Rank reported a position in AdaptHealth (AHCO) for Q1 2022, worth a combined $1.52B — down 29% from $2.15B a quarter earlier.
Buyers outnumbered sellers: 27 funds opened new AHCO positions and 22 closed out — a net gain of 5 holders — while 60 added to existing stakes and 45 trimmed.
The largest buyer was Morgan Stanley, adding an estimated $106M. The largest seller was Viking Global Investors, exiting entirely with an estimated $96.6M sold.
- 154 institutional investors held AdaptHealth (AHCO) as of Q1 2022, up from 152 in Q4 2021.
- Funds reported $1.52B of AdaptHealth stock for Q1 2022, down 29% quarter-over-quarter.
- 27 funds opened new AdaptHealth positions in Q1 2022 and 22 closed out, a net change of +5 holders.
- The largest AdaptHealth buyer in Q1 2022 was Morgan Stanley, an estimated $106M added.
- The largest AdaptHealth seller in Q1 2022 was Viking Global Investors, an estimated $96.6M sold.
Based on aggregated 13F filings for Q1 2022.